Tar Heel Times
Your comprehensive source for Tar Heel sports news

UNC ranked 7th among biomedical research institutions

Researchers at the University of North Carolina at Chapel Hill are using genetically engineered mouse models to help predict how humans will respond to different chemotherapy drug combinations used to fight breast cancer. Last year, UNC scientists identified biomarkers for challenging molecular subtypes of human breast cancer in genetically engineered mice, specifically looking for types that have few known targets and available therapies. (Fierce Biotech Research)

Share: Facebook | Twitter | Email


Recent Campus Connections News:

Carolina researchers earn five NIH BRAIN Initiative grants

'Stupid has a high price': Chandler Kania found guilty of involuntary manslaughter

EPA awards multimillion-dollar contract to Carolina to protect air quality

UNC organizations part of hurricane relief efforts for Eastern N.C.

Gimghoul Castle still a source of lore in Chapel Hill

© 2005-2016 Tar Heel Times | Contact | Privacy Policy | Site Map | RSS | Did UNC Win?

Tar Heel Times is an unofficial resource for UNC fans and is not affiliated with the University of North Carolina.